These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 15582270

  • 1. Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985-2000.
    Visioli CB, Zappa M, Ciatto S, Iossa A, Crocetti E.
    Cancer Detect Prev; 2004; 28(6):461-4. PubMed ID: 15582270
    [Abstract] [Full Text] [Related]

  • 2. Trends in incidence rates of oesophagus and gastric cancer in Italy by subsite and histology, 1986-1997.
    Orengo MA, Casella C, Fontana V, Filiberti R, Conio M, Rosso S, Tumino R, Crosignani P, De Lisi V, Falcini F, Vercelli M, AIRT Working Group.
    Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):739-46. PubMed ID: 16772831
    [Abstract] [Full Text] [Related]

  • 3. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S.
    J Natl Cancer Inst; 2008 May 07; 100(9):622-9. PubMed ID: 18445828
    [Abstract] [Full Text] [Related]

  • 4. The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy.
    Crocetti E, Battisti L, Betta A, Palma PD, Paci E, Piffer S, Pojer A, Polla E, Zappa M.
    Eur J Cancer Prev; 2007 Dec 07; 16(6):564-7. PubMed ID: 18090131
    [Abstract] [Full Text] [Related]

  • 5. Trends in cancer of the cervix uteri in Sweden following cytological screening.
    Bergström R, Sparén P, Adami HO.
    Br J Cancer; 1999 Sep 07; 81(1):159-66. PubMed ID: 10487628
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S, Morrell S, Zuo Y, Baker D.
    J Med Screen; 2008 Sep 07; 15(1):36-43. PubMed ID: 18416954
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Incidence of adenocarcinoma of the uterine cervix in mass cytological and colposcopic diagnostic studies].
    Pieroni G, Cariaggi P, Ottaviano M, Marchionni M, Mincione G, Bartoloni St Omer F.
    Minerva Ginecol; 1975 May 07; 27(5):418-21. PubMed ID: 1134695
    [No Abstract] [Full Text] [Related]

  • 14. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.
    Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Møller H, Hakama M, Parkin DM.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar 07; 14(3):677-86. PubMed ID: 15767349
    [Abstract] [Full Text] [Related]

  • 15. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival.
    Sherman ME, Wang SS, Carreon J, Devesa SS.
    Cancer; 2005 Mar 15; 103(6):1258-64. PubMed ID: 15693030
    [Abstract] [Full Text] [Related]

  • 16. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
    Sigurdsson K.
    Acta Obstet Gynecol Scand; 1999 Jul 15; 78(6):478-85. PubMed ID: 10376856
    [Abstract] [Full Text] [Related]

  • 17. Incidence trends of cervical cancer in Puerto Rico, 1987-2004.
    Pérez-Irizarry J, Nazario-Delgado CM, De la Torre T, Ortiz-Ortiz KJ, Torres-Cintrón M, Figueroa-Vallés NR.
    P R Health Sci J; 2010 Dec 15; 29(4):364-71. PubMed ID: 21261175
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [No major difference between population screening for cervical carcinoma at the present screening interval of 5 years and the former interval of 3 years].
    Vinkesteijn AS, Siemens FC, Boon ME, Kuypers JC, Kok LP.
    Ned Tijdschr Geneeskd; 2004 Sep 04; 148(36):1781-5. PubMed ID: 15495942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.